One month left to apply for 3 grants issued by the Alzheimer’s Drug Discovery Foundation:
This seeks to create and support innovative translational research programmes for Alzheimer’s disease, related dementias and cognitive ageing in academic medical centres and universities. Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.
Grants average $150,000 per year for up to two years.
Two programmes are available:
•the biotechnology development programme supports qualified scientific projects in existing, private, early-stage biotechnology companies and will provide support to more advanced companies if a clear need for non-profit funding is demonstrated;
•the biotechnology founders technology transfer programme supports academic programmes that are eligible for technology transfer and the start-up of new biotechnology companies with projects dedicated to Alzheimer’s disease and related dementias.
Grants average between $100,000 and $300,000 per year for preclinical projects. Budget requests up to $1.5 million are accepted for clinical trial submissions. Support is provided for personnel costs, supplies, small non-durable equipment up to $2,500, consultants and patient costs related to clinical trials.
These support conferences that stimulate new ideas and approaches in Alzheimer’s disease and cognitive ageing.
Conferences should bring together physicians, scientists and policymakers from the US and from the international community.
The deadline for all grants is 26 Nov 2015.
For more information, please visit: http://www.alzdiscovery.org/research-and-grants/applyforfunding
For advice on applying, please contact your relevant Research Development Manager.